88 related articles for article (PubMed ID: 19720917)
1. Interleukin-12 receptor beta2: from cytokine receptor to gatekeeper gene in human B-cell malignancies.
Pistoia V; Cocco C; Airoldi I
J Clin Oncol; 2009 Oct; 27(28):4809-16. PubMed ID: 19720917
[TBL] [Abstract][Full Text] [Related]
2. Methylation of the IL-12Rbeta2 gene as novel tumor escape mechanism for pediatric B-acute lymphoblastic leukemia cells.
Airoldi I; Cocco C; Di Carlo E; Disarò S; Ognio E; Basso G; Pistoia V
Cancer Res; 2006 Apr; 66(8):3978-80. PubMed ID: 16618714
[TBL] [Abstract][Full Text] [Related]
3. The interleukin-12 and interleukin-12 receptor system in normal and transformed human B lymphocytes.
Airoldi I; Guglielmino R; Carra G; Corcione A; Gerosa F; Taborelli G; Trinchieri G; Pistoia V
Haematologica; 2002 Apr; 87(4):434-42. PubMed ID: 11940489
[TBL] [Abstract][Full Text] [Related]
4. Differential DNA methylation of gene promoters in small B-cell lymphomas.
Guo J; Burger M; Nimmrich I; Maier S; Becker E; Genc B; Duff D; Rahmatpanah F; Chitma-Matsiga R; Shi H; Berlin K; Huang TH; Caldwell CW
Am J Clin Pathol; 2005 Sep; 124(3):430-9. PubMed ID: 16191512
[TBL] [Abstract][Full Text] [Related]
5. Differential expression and function of human IL-12Rβ2 polymorphic variants.
de Paus RA; Geilenkirchen MA; van Riet S; van Dissel JT; van de Vosse E
Mol Immunol; 2013 Dec; 56(4):380-9. PubMed ID: 23911393
[TBL] [Abstract][Full Text] [Related]
6. The IL-12Rbeta2 gene functions as a tumor suppressor in human B cell malignancies.
Airoldi I; Di Carlo E; Banelli B; Moserle L; Cocco C; Pezzolo A; Sorrentino C; Rossi E; Romani M; Amadori A; Pistoia V
J Clin Invest; 2004 Jun; 113(11):1651-9. PubMed ID: 15173892
[TBL] [Abstract][Full Text] [Related]
7. [Interleukin 12 (IL-12) and its receptor].
Szeliga J; Gościcka T
Postepy Hig Med Dosw; 2002; 56(2):185-99. PubMed ID: 12107962
[TBL] [Abstract][Full Text] [Related]
8. IFN-beta inhibits human Th17 cell differentiation.
Ramgolam VS; Sha Y; Jin J; Zhang X; Markovic-Plese S
J Immunol; 2009 Oct; 183(8):5418-27. PubMed ID: 19783688
[TBL] [Abstract][Full Text] [Related]
9. Improvement of rituximab efficiency in chronic lymphocytic leukemia by CpG-mediated upregulation of CD20 expression independently of PU.1.
Mankaï A; Buhé V; Hammadi M; Youinou P; Ghedira I; Berthou C; Bordron A
Ann N Y Acad Sci; 2009 Sep; 1173():721-8. PubMed ID: 19758221
[TBL] [Abstract][Full Text] [Related]
10. IL-21 and IL-10 have redundant roles but differential capacities at different stages of Plasma Cell generation from human Germinal Center B cells.
Yoon SO; Zhang X; Berner P; Choi YS
J Leukoc Biol; 2009 Dec; 86(6):1311-8. PubMed ID: 19762555
[TBL] [Abstract][Full Text] [Related]
11. High expression of the inhibitory receptor BTLA in T-follicular helper cells and in B-cell small lymphocytic lymphoma/chronic lymphocytic leukemia.
M'Hidi H; Thibult ML; Chetaille B; Rey F; Bouadallah R; Nicollas R; Olive D; Xerri L
Am J Clin Pathol; 2009 Oct; 132(4):589-96. PubMed ID: 19762537
[TBL] [Abstract][Full Text] [Related]
12. Establishment of humanized anti-interleukin-5 receptor alpha chain monoclonal antibodies having a potent neutralizing activity.
Koike M; Nakamura K; Furuya A; Iida A; Anazawa H; Takatsu K; Hanai N
Hum Antibodies; 2009; 18(1-2):17-27. PubMed ID: 19478395
[TBL] [Abstract][Full Text] [Related]
13. Epigenetic inactivation of the circadian clock gene BMAL1 in hematologic malignancies.
Taniguchi H; Fernández AF; Setién F; Ropero S; Ballestar E; Villanueva A; Yamamoto H; Imai K; Shinomura Y; Esteller M
Cancer Res; 2009 Nov; 69(21):8447-54. PubMed ID: 19861541
[TBL] [Abstract][Full Text] [Related]
14. Intratumoral production of IL-6 in B cell chronic lymphocytic leukemia and B lymphomas.
Emilie D; Leger-Ravet MB; Devergne O; Raphael M; Peuchmaur M; Coumbaras J; Crevon MC; Galanaud P
Leuk Lymphoma; 1993 Nov; 11(5-6):411-7. PubMed ID: 8124214
[TBL] [Abstract][Full Text] [Related]
15. Role of decreased production of interleukin-10 and interferon-gamma in spontaneous apoptosis of B-chronic lymphocytic leukemia lymphocytes in vitro.
Djurdjevic P; Zelen I; Ristic P; Baskic D; Popovic S; Arsenijevic N
Arch Med Res; 2009 Jul; 40(5):357-63. PubMed ID: 19766898
[TBL] [Abstract][Full Text] [Related]
16. The transition to the metastatic phenotype of rat lymphoma cells involves up-regulation of IL-10 receptor expression and IL-10 secretion.
Rico MJ; Matar P; Gervasoni SI; Bonfil RD; Calcaterra N; Scharovsky OG
Clin Exp Metastasis; 2005; 22(2):127-35. PubMed ID: 16086233
[TBL] [Abstract][Full Text] [Related]
17. Transformation of chronic lymphocytic leukemia/small lymphocytic lymphoma to interdigitating dendritic cell sarcoma: evidence for transdifferentiation of the lymphoma clone.
Fraser CR; Wang W; Gomez M; Zhang T; Mathew S; Furman RR; Knowles DM; Orazi A; Tam W
Am J Clin Pathol; 2009 Dec; 132(6):928-39. PubMed ID: 19926586
[TBL] [Abstract][Full Text] [Related]
18. Macrophage- and dendritic-cell-derived interleukin-15 receptor alpha supports homeostasis of distinct CD8+ T cell subsets.
Mortier E; Advincula R; Kim L; Chmura S; Barrera J; Reizis B; Malynn BA; Ma A
Immunity; 2009 Nov; 31(5):811-22. PubMed ID: 19913445
[TBL] [Abstract][Full Text] [Related]
19. IL-10-producing B cells are characterized by a specific methylation signature.
Tonon S; Mion F; Dong J; Chang HD; Dalla E; Scapini P; Perruolo G; Zanello A; Dugo M; Cassatella MA; Colombo MP; Radbruch A; Tripodo C; Pucillo CE
Eur J Immunol; 2019 Aug; 49(8):1213-1225. PubMed ID: 31034584
[TBL] [Abstract][Full Text] [Related]
20. Protein kinase B/Akt signals impair Th17 differentiation and support natural regulatory T cell function and induced regulatory T cell formation.
Pierau M; Engelmann S; Reinhold D; Lapp T; Schraven B; Bommhardt UH
J Immunol; 2009 Nov; 183(10):6124-34. PubMed ID: 19841181
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
